Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Influenza

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 328 articles:
HTML format



Single Articles


    May 2021
  1. KANG S, Tanaka T, Inoue H, Ono C, et al
    Reply to Cheng et al.: COVID-19 induces lower extent of cytokines, but damages vascular endothelium by IL-6 signaling.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  2. CHENG L, Zhu Z, Wang C, Wang P, et al
    COVID-19 induces lower levels of IL-8, IL-10, and MCP-1 than other acute CRS-inducing diseases.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  3. ZHANG L, Richards A, Barrasa MI, Hughes SH, et al
    Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  4. GENG X, Katul GG, Gerges F, Bou-Zeid E, et al
    A kernel-modulated SIR model for Covid-19 contagious spread from county to continent.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  5. STAMBAUGH A, Parks JW, Stott MA, Meena GG, et al
    Optofluidic multiplex detection of single SARS-CoV-2 and influenza A antigens using a novel bright fluorescent probe assay.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  6. MILKMAN KL, Patel MS, Gandhi L, Graci HN, et al
    A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor's appointment.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  7. MALONE B, Chen J, Wang Q, Llewellyn E, et al
    Structural basis for backtracking by the SARS-CoV-2 replication-transcription complex.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  8. DONG C, Wang Y, Gonzalez GX, Ma Y, et al
    Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  9. MORSELLI GYSI D, do Valle I, Zitnik M, Ameli A, et al
    Network medicine framework for identifying drug-repurposing opportunities for COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  10. NI X, Ouyang W, Jeong H, Kim JT, et al
    Automated, multiparametric monitoring of respiratory biomarkers and vital signs in clinical and home settings for COVID-19 patients.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  11. PYMM P, Adair A, Chan LJ, Cooney JP, et al
    Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  12. MAEDA DLNF, Tian D, Yu H, Dar N, et al
    Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  13. SAWATZKI K, Hill NJ, Puryear WB, Foss AD, et al
    Host barriers to SARS-CoV-2 demonstrated by ferrets in a high-exposure domestic setting.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  14. BAIR E, Stillinger T, Rittger K, Skiles M, et al
    COVID-19 lockdowns show reduced pollution on snow and ice in the Indus River Basin.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    April 2021
  15. TKACHENKO AV, Maslov S, Elbanna A, Wong GN, et al
    Time-dependent heterogeneity leads to transient suppression of the COVID-19 epidemic, not herd immunity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  16. MENA EL, Donahue CJ, Vaites LP, Li J, et al
    ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  17. ENGZELL P, Frey A, Verhagen MD
    Learning loss due to school closures during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  18. BAZANT MZ, Bush JWM
    A guideline to limit indoor airborne transmission of COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  19. YAN Y, Malik AA, Bayham J, Fenichel EP, et al
    Measuring voluntary and policy-induced social distancing behavior during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  20. BUCKNER JH, Chowell G, Springborn MR
    Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  21. PRESTON SH, Vierboom YC
    Excess mortality in the United States in the 21st century.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  22. CASTRO MC, Singer B
    Prioritizing COVID-19 vaccination by age.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  23. KRAUS S, Koch N
    Provisional COVID-19 infrastructure induces large, rapid increases in cycling.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  24. RIZZI S, Vaupel JW
    Short-term forecasts of expected deaths.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  25. HE X, Quan S, Xu M, Rodriguez S, et al
    Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  26. BERRY CR, Fowler A, Glazer T, Handel-Meyer S, et al
    Evaluating the effects of shelter-in-place policies during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  27. GRANGE ZL, Goldstein T, Johnson CK, Anthony S, et al
    Ranking the risk of animal-to-human spillover for newly discovered viruses.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  28. KORN L, Bohm R, Betsch C
    Reply to Rabb et al.: Why promoting COVID-19 vaccines with community immunity is not a good strategy (yet).
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  29. SNEPPEN K, Nielsen BF, Taylor RJ, Simonsen L, et al
    Overdispersion in COVID-19 increases the effectiveness of limiting nonrepetitive contacts for transmission control.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  30. BJERRE-NIELSEN A, Kassarnig V, Lassen DD, Lehmann S, et al
    Task-specific information outperforms surveillance-style big data in predictive analytics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    March 2021
  31. WEISEL O
    Vaccination as a social contract: The case of COVID-19 and US political partisanship.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  32. HONG B, Bonczak BJ, Gupta A, Thorpe LE, et al
    Exposure density and neighborhood disparities in COVID-19 infection risk.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  33. CONLEY D, Johnson T
    Opinion: Past is future for the era of COVID-19 research in the social sciences.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  34. MENDELS DA, Dortet L, Emeraud C, Oueslati S, et al
    Using artificial intelligence to improve COVID-19 rapid diagnostic test result interpretation.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  35. LIU Y, Hu G, Wang Y, Ren W, et al
    Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  36. SINGH S, Shaikh M, Hauck K, Miraldo M, et al
    Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  37. LIU R, Americo JL, Cotter CA, Earl PL, et al
    One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  38. LU M, Dravid P, Zhang Y, Trivedi S, et al
    A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  39. DAMIALIS A, Gilles S, Sofiev M, Sofieva V, et al
    Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  40. GIURGE LM, Whillans AV, Yemiscigil A
    A multicountry perspective on gender differences in time use during COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  41. JI W, Li X, Chen S, Ren L, et al
    Transmission of SARS-CoV-2 via fomite, especially cold chain, should not be ignored.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  42. SHUMSKY RA, Debo L, Lebeaux RM, Nguyen QP, et al
    Retail store customer flow and COVID-19 transmission.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  43. GOLDSTEIN JR, Cassidy T, Wachter KW
    Vaccinating the oldest against COVID-19 saves both the most lives and most years of life.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  44. KIZILCEC RF, Makridis CA, Sadowski KC
    Pandemic response policies' democratizing effects on online learning.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  45. THURNER S, Klimek P, Hanel R
    Reply to Kusmierz and Toyoizumi: A network-based explanation of why most COVID-19 infection curves are linear.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  46. KAPLAN RM, Milstein A
    Influence of a COVID-19 vaccine's effectiveness and safety profile on vaccination acceptance.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  47. LI K, Jacob DJ, Liao H, Qiu Y, et al
    Ozone pollution in the North China Plain spreading into the late-winter haze season.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  48. ZEBERG H, Paabo S
    A genomic region associated with protection against severe COVID-19 is inherited from Neandertals.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  49. CLARK SJ, Turner AN
    Monitoring epidemics: Lessons from measuring population prevalence of the coronavirus.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  50. BENTON DJ, Wrobel AG, Roustan C, Borg A, et al
    The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  51. VLACHOS J, Hertegard E, B Svaleryd H
    The effects of school closures on SARS-CoV-2 among parents and teachers.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  52. GIUNTELLA O, Hyde K, Saccardo S, Sadoff S, et al
    Lifestyle and mental health disruptions during COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  53. SUBRAMANIAN R, He Q, Pascual M
    Quantifying asymptomatic infection and transmission of COVID-19 in New York City using observed cases, serology, and testing capacity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  54. NADEAU SA, Vaughan TG, Scire J, Huisman JS, et al
    The origin and early spread of SARS-CoV-2 in Europe.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    February 2021
  55. FREYN AW, Han J, Guthmiller JJ, Bailey MJ, et al
    Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  56. LI Z, Lin Y, Huang YY, Liu R, et al
    Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  57. MA C, Wang J
    Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  58. EDWARDS DA, Ausiello D, Salzman J, Devlin T, et al
    Exhaled aerosol increases with COVID-19 infection, age, and obesity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  59. PERRY BL, Aronson B, Pescosolido BA
    Pandemic precarity: COVID-19 is exposing and exacerbating inequalities in the American heartland.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  60. FAZIO RH, Ruisch BC, Moore CA, Granados Samayoa JA, et al
    Social distancing decreases an individual's likelihood of contracting COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  61. NEANT N, Lingas G, Le Hingrat Q, Ghosn J, et al
    Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  62. AZIMI P, Keshavarz Z, Cedeno Laurent JG, Stephens B, et al
    Mechanistic transmission modeling of COVID-19 on the Diamond Princess cruise ship demonstrates the importance of aerosol transmission.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  63. TORRATS-ESPINOSA G
    Using machine learning to estimate the effect of racial segregation on COVID-19 mortality in the United States.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  64. KVEDARAITE E, Hertwig L, Sinha I, Ponzetta A, et al
    Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  65. LAPOINTE CP, Grosely R, Johnson AG, Wang J, et al
    Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  66. FINLAY BB, Amato KR, Azad M, Blaser MJ, et al
    The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  67. WITTEMAN HO, Haverfield J, Tannenbaum C
    COVID-19 gender policy changes support female scientists and improve research quality.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  68. SASISEKHARAN V, Pentakota N, Jayaraman A, Tharakaraman K, et al
    Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  69. ANDRASFAY T, Goldman N
    Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  70. YIANNOUTSOS CT, Halverson PK, Menachemi N
    Bayesian estimation of SARS-CoV-2 prevalence in Indiana by random testing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  71. BORCHERING RK, Gunning CE, Gokhale DV, Weedop KB, et al
    Anomalous influenza seasonality in the United States and the emergence of novel influenza B viruses.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  72. JAN JT, Cheng TR, Juang YP, Ma HH, et al
    Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    January 2021
  73. HOWARD J, Huang A, Li Z, Tufekci Z, et al
    An evidence review of face masks against COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  74. MARZIANO V, Guzzetta G, Rondinone BM, Boccuni F, et al
    Retrospective analysis of the Italian exit strategy from COVID-19 lockdown.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  75. BERGER L, Berger N, Bosetti V, Gilboa I, et al
    Rational policymaking during a pandemic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  76. HANNA CC, Ashhurst AS, Quan D, Maxwell JWC, et al
    Synthetic protein conjugate vaccines provide protection against Mycobacterium tuberculosis in mice.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  77. GIGLIO S, Maggiori M, Stroebel J, Utkus S, et al
    The joint dynamics of investor beliefs and trading during the COVID-19 crash.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  78. HOPKINS DJ, Meredith M, Chainani A, Olin N, et al
    Results from a 2020 field experiment encouraging voting by mail.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  79. RAPPUOLI R, De Gregorio E, Del Giudice G, Phogat S, et al
    Vaccinology in the post-COVID-19 era.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  80. VOUTOURI C, Nikmaneshi MR, Hardin CC, Patel AB, et al
    In silico dynamics of COVID-19 phenotypes for optimizing clinical management.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  81. EVENSEN D, Whitmarsh L, Bartie P, Devine-Wright P, et al
    Effect of "finite pool of worry" and COVID-19 on UK climate change perceptions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  82. PARK SW, Sun K, Champredon D, Li M, et al
    Forward-looking serial intervals correctly link epidemic growth to reproduction numbers.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  83. BERENBAUM MR
    On COVID-19, cognitive bias, and open access.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  84. CHEN MK, Chevalier JA, Long EF
    Nursing home staff networks and COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  85. CARLETON T, Cornetet J, Huybers P, Meng KC, et al
    Global evidence for ultraviolet radiation decreasing COVID-19 growth rates.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  86. CIPPA PE, Cugnata F, Ferrari P, Brombin C, et al
    A data-driven approach to identify risk profiles and protective drugs in COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  87. LI R
    Mobility restrictions are more than transient reduction of travel activities.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  88. SIMONESCHI D
    Opinion: We need to improve the welfare of life science trainees.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  89. LIU K, Tan S, Niu S, Wang J, et al
    Cross-species recognition of SARS-CoV-2 to bat ACE2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  90. MUELLER JT, McConnell K, Burow PB, Pofahl K, et al
    Impacts of the COVID-19 pandemic on rural America.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  91. JUNG H, Albarracin D
    Concerns for others increases the likelihood of vaccination against influenza and COVID-19 more in sparsely rather than densely populated areas.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  92. SCHMELZ K
    Enforcement may crowd out voluntary support for COVID-19 policies, especially where trust in government is weak and in a liberal society.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    December 2020
  93. SCHLOSSER F, Maier BF, Jack O, Hinrichs D, et al
    COVID-19 lockdown induces disease-mitigating structural changes in mobility networks.
    Proc Natl Acad Sci U S A. 2020;117:32883-32890.
    PubMed     Abstract available


  94. CENTOLA D
    Considering network interventions.
    Proc Natl Acad Sci U S A. 2020;117:32833-32835.
    PubMed    


  95. MITZE T, Kosfeld R, Rode J, Walde K, et al
    Face masks considerably reduce COVID-19 cases in Germany.
    Proc Natl Acad Sci U S A. 2020;117:32293-32301.
    PubMed     Abstract available


  96. WEITZ JS, Park SW, Eksin C, Dushoff J, et al
    Awareness-driven behavior changes can shift the shape of epidemics away from peaks and toward plateaus, shoulders, and oscillations.
    Proc Natl Acad Sci U S A. 2020;117:32764-32771.
    PubMed     Abstract available


  97. ZANG R, Case JB, Yutuc E, Ma X, et al
    Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion.
    Proc Natl Acad Sci U S A. 2020;117:32105-32113.
    PubMed     Abstract available


  98. TUPPER P, Boury H, Yerlanov M, Colijn C, et al
    Event-specific interventions to minimize COVID-19 transmission.
    Proc Natl Acad Sci U S A. 2020;117:32038-32045.
    PubMed     Abstract available


  99. TAYLOR CA, Boulos C, Almond D
    Livestock plants and COVID-19 transmission.
    Proc Natl Acad Sci U S A. 2020;117:31706-31715.
    PubMed     Abstract available


  100. WANG Y, Mao Q, Zhou X
    Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions?
    Proc Natl Acad Sci U S A. 2020;117:30896-30897.
    PubMed    


  101. ZENG HL, Dichio V, Rodriguez Horta E, Thorell K, et al
    Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes.
    Proc Natl Acad Sci U S A. 2020;117:31519-31526.
    PubMed     Abstract available


  102. XU X, Han M, Li T, Sun W, et al
    Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients.
    Proc Natl Acad Sci U S A. 2020;117:30898-30899.
    PubMed    


  103. YANG C, Liu E, Liu M
    Safety concerns regarding concomitant use of tocilizumab and glucocorticoids in COVID-19 patients.
    Proc Natl Acad Sci U S A. 2020;117:30025-30026.
    PubMed    


  104. XU X, Han M, Li T, Sun W, et al
    Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention.
    Proc Natl Acad Sci U S A. 2020;117:30027-30028.
    PubMed    


  105. NISHI A, Dewey G, Endo A, Neman S, et al
    Network interventions for managing the COVID-19 pandemic and sustaining economy.
    Proc Natl Acad Sci U S A. 2020;117:30285-30294.
    PubMed     Abstract available


  106. CASADEVALL A, Pirofski LA
    In fatal COVID-19, the immune response can control the virus but kill the patient.
    Proc Natl Acad Sci U S A. 2020;117:30009-30011.
    PubMed    


  107. KORTESSIS N, Simon MW, Barfield M, Glass GE, et al
    The interplay of movement and spatiotemporal variation in transmission degrades pandemic control.
    Proc Natl Acad Sci U S A. 2020;117:30104-30106.
    PubMed     Abstract available


  108. BAKER RE, Park SW, Yang W, Vecchi GA, et al
    The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections.
    Proc Natl Acad Sci U S A. 2020;117:30547-30553.
    PubMed     Abstract available


  109. BANG A, Khadakkar S
    Opinion: Biodiversity conservation during a global crisis: Consequences and the way forward.
    Proc Natl Acad Sci U S A. 2020;117:29995-29999.
    PubMed    


    November 2020
  110. HORNER C, Schurmann C, Auste A, Ebenig A, et al
    A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine.
    Proc Natl Acad Sci U S A. 2020 Nov 30. pii: 2014468117.
    PubMed     Abstract available


  111. SRIRAM K, Loomba R, Insel PA
    Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.
    Proc Natl Acad Sci U S A. 2020;117:29274-29282.
    PubMed     Abstract available


  112. RELMAN DA
    Opinion: To stop the next pandemic, we need to unravel the origins of COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:29246-29248.
    PubMed    


  113. LI W, Chen C, Drelich A, Martinez DR, et al
    Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2020;117:29832-29838.
    PubMed     Abstract available


  114. STOKES GL, Lynch AJ, Lowe BS, Funge-Smith S, et al
    COVID-19 pandemic impacts on global inland fisheries.
    Proc Natl Acad Sci U S A. 2020;117:29419-29421.
    PubMed     Abstract available


  115. WONG F, Collins JJ
    Evidence that coronavirus superspreading is fat-tailed.
    Proc Natl Acad Sci U S A. 2020;117:29416-29418.
    PubMed     Abstract available


  116. SENDER V, Hentrich K, Pathak A, Tan Qian Ler A, et al
    Capillary leakage provides nutrients and antioxidants for rapid pneumococcal proliferation in influenza-infected lower airways.
    Proc Natl Acad Sci U S A. 2020 Nov 23. pii: 2012265117.
    PubMed     Abstract available


  117. WESTON S, Baracco L, Keller C, Matthews K, et al
    The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses.
    Proc Natl Acad Sci U S A. 2020 Nov 12. pii: 2012939117.
    PubMed     Abstract available


  118. MIORIN L, Kehrer T, Sanchez-Aparicio MT, Zhang K, et al
    SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
    Proc Natl Acad Sci U S A. 2020;117:28344-28354.
    PubMed     Abstract available


  119. SEITZ BM, Aktipis A, Buss DM, Alcock J, et al
    The pandemic exposes human nature: 10 evolutionary insights.
    Proc Natl Acad Sci U S A. 2020;117:27767-27776.
    PubMed     Abstract available


  120. LUMENG JC, Chavous TM, Lok AS, Sen S, et al
    Opinion: A risk-benefit framework for human research during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2020;117:27749-27753.
    PubMed    


  121. POLYAKOVA M, Kocks G, Udalova V, Finkelstein A, et al
    Initial economic damage from the COVID-19 pandemic in the United States is more widespread across ages and geographies than initial mortality impacts.
    Proc Natl Acad Sci U S A. 2020;117:27934-27939.
    PubMed     Abstract available


  122. WU M, Chen Y, Xia H, Wang C, et al
    Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
    Proc Natl Acad Sci U S A. 2020;117:28336-28343.
    PubMed     Abstract available


  123. DOLGIN E
    Core Concept: The pandemic is prompting widespread use-and misuse-of real-world data.
    Proc Natl Acad Sci U S A. 2020;117:27754-27758.
    PubMed    


  124. XIONG C, Hu S, Yang M, Luo W, et al
    Mobile device data reveal the dynamics in a positive relationship between human mobility and COVID-19 infections.
    Proc Natl Acad Sci U S A. 2020;117:27087-27089.
    PubMed     Abstract available


  125. GALASSO V, Pons V, Profeta P, Becher M, et al
    Gender differences in COVID-19 attitudes and behavior: Panel evidence from eight countries.
    Proc Natl Acad Sci U S A. 2020;117:27285-27291.
    PubMed     Abstract available


  126. MEROW C, Urban MC
    Seasonality and uncertainty in global COVID-19 growth rates.
    Proc Natl Acad Sci U S A. 2020;117:27456-27464.
    PubMed     Abstract available


  127. LI Z, Li X, Huang YY, Wu Y, et al
    Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs.
    Proc Natl Acad Sci U S A. 2020;117:27381-27387.
    PubMed     Abstract available


  128. WITTEVEEN D, Velthorst E
    Economic hardship and mental health complaints during COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:27277-27284.
    PubMed     Abstract available


  129. RAO L, Xia S, Xu W, Tian R, et al
    Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines.
    Proc Natl Acad Sci U S A. 2020;117:27141-27147.
    PubMed     Abstract available


  130. KAMPF G
    Protective effect of mandatory face masks in the public-relevant variables with likely impact on outcome were not considered.
    Proc Natl Acad Sci U S A. 2020;117:27076-27077.
    PubMed    


  131. NG QX, De Deyn MLZQ, Yeo WS
    Do face masks help? is not the question.
    Proc Natl Acad Sci U S A. 2020;117:27078-27079.
    PubMed    


    October 2020
  132. KAHN JP, Henry LM, Mastroianni AC, Chen WH, et al
    Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.
    Proc Natl Acad Sci U S A. 2020 Oct 29. pii: 2021189117.
    PubMed    


  133. SORG RA, Gallay C, Van Maele L, Sirard JC, et al
    Synthetic gene-regulatory networks in the opportunistic human pathogen Streptococcus pneumoniae.
    Proc Natl Acad Sci U S A. 2020 Oct 21. pii: 1920015117.
    PubMed     Abstract available


  134. DOWD JB, Block P, Rotondi V, Mills MC, et al
    Dangerous to claim "no clear association" between intergenerational relationships and COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:25975-25976.
    PubMed    


  135. ARPINO B, Bordone V, Pasqualini M
    Reply to Dowd et al.: Dangerous to overemphasize the importance of specific COVID-19 risk factors based on (unadjusted) macro-level analyses.
    Proc Natl Acad Sci U S A. 2020;117:25977-25978.
    PubMed    


  136. CASTRO M, Ares S, Cuesta JA, Manrubia S, et al
    The turning point and end of an expanding epidemic cannot be precisely forecast.
    Proc Natl Acad Sci U S A. 2020;117:26190-26196.
    PubMed     Abstract available


  137. MCDERMOTT A
    Inner Workings: Researchers race to develop in-home testing for COVID-19, a potential game changer.
    Proc Natl Acad Sci U S A. 2020;117:25956-25959.
    PubMed    


  138. BOSCO-LAUTH AM, Hartwig AE, Porter SM, Gordy PW, et al
    Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats.
    Proc Natl Acad Sci U S A. 2020;117:26382-26388.
    PubMed     Abstract available


  139. LI R, Chen B, Zhang T, Ren Z, et al
    Global COVID-19 pandemic demands joint interventions for the suppression of future waves.
    Proc Natl Acad Sci U S A. 2020;117:26151-26157.
    PubMed     Abstract available


  140. CHENG MH, Zhang S, Porritt RA, Noval Rivas M, et al
    Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
    Proc Natl Acad Sci U S A. 2020;117:25254-25262.
    PubMed     Abstract available


  141. ABKARIAN M, Mendez S, Xue N, Yang F, et al
    Speech can produce jet-like transport relevant to asymptomatic spreading of virus.
    Proc Natl Acad Sci U S A. 2020;117:25237-25245.
    PubMed     Abstract available


  142. YAM KC, Jackson JC, Barnes CM, Lau J, et al
    The rise of COVID-19 cases is associated with support for world leaders.
    Proc Natl Acad Sci U S A. 2020;117:25429-25433.
    PubMed     Abstract available


  143. NETZ RR, Eaton WA
    Physics of virus transmission by speaking droplets.
    Proc Natl Acad Sci U S A. 2020;117:25209-25211.
    PubMed     Abstract available


  144. WILDER B, Charpignon M, Killian JA, Ou HC, et al
    Modeling between-population variation in COVID-19 dynamics in Hubei, Lombardy, and New York City.
    Proc Natl Acad Sci U S A. 2020;117:25904-25910.
    PubMed     Abstract available


  145. BRETT TS, Rohani P
    Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies.
    Proc Natl Acad Sci U S A. 2020;117:25897-25903.
    PubMed     Abstract available


  146. RAKER EJ, Zacher M, Lowe SR
    Reply to Ng et al.: Not all trauma is the same, but lessons can be drawn from commonalities.
    Proc Natl Acad Sci U S A. 2020;117:25201-25202.
    PubMed    


  147. NG QX, Lim DY, Chee KT
    Not all trauma is the same.
    Proc Natl Acad Sci U S A. 2020;117:25200.
    PubMed    


  148. HEINDEL DW, Koppolu S, Zhang Y, Kasper B, et al
    Glycomic analysis of host response reveals high mannose as a key mediator of influenza severity.
    Proc Natl Acad Sci U S A. 2020 Oct 12. pii: 2008203117.
    PubMed     Abstract available


  149. LOCKHART M, Hill SJ, Merolla J, Romero M, et al
    America's electorate is increasingly polarized along partisan lines about voting by mail during the COVID-19 crisis.
    Proc Natl Acad Sci U S A. 2020;117:24640-24642.
    PubMed     Abstract available


  150. HOLLAND KJ, Cortina LM, Magley VJ, Baker AL, et al
    Don't let COVID-19 disrupt campus climate surveys of sexual harassment.
    Proc Natl Acad Sci U S A. 2020;117:24606-24608.
    PubMed    


  151. SEGALES J, Puig M, Rodon J, Avila-Nieto C, et al
    Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain.
    Proc Natl Acad Sci U S A. 2020;117:24790-24793.
    PubMed     Abstract available


  152. HOLTER JC, Pischke SE, de Boer E, Lind A, et al
    Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.
    Proc Natl Acad Sci U S A. 2020;117:25018-25025.
    PubMed     Abstract available


  153. STEINMAN JB, Lum FM, Ho PP, Kaminski N, et al
    Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics.
    Proc Natl Acad Sci U S A. 2020;117:24620-24626.
    PubMed     Abstract available


    September 2020
  154. ARORA VM, Wray CM, O'Glasser AY, Shapiro M, et al
    Using the curriculum vitae to promote gender equity during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2020;117:24032.
    PubMed    


  155. GROSSMAN G, Kim S, Rexer JM, Thirumurthy H, et al
    Political partisanship influences behavioral responses to governors' recommendations for COVID-19 prevention in the United States.
    Proc Natl Acad Sci U S A. 2020;117:24144-24153.
    PubMed     Abstract available


  156. THOMAS LJ, Huang P, Yin F, Luo XI, et al
    Spatial heterogeneity can lead to substantial local variations in COVID-19 timing and severity.
    Proc Natl Acad Sci U S A. 2020;117:24180-24187.
    PubMed     Abstract available


  157. HABEL JR, Nguyen THO, van de Sandt CE, Juno JA, et al
    Suboptimal SARS-CoV-2-specific CD8(+) T cell response associated with the prominent HLA-A*02:01 phenotype.
    Proc Natl Acad Sci U S A. 2020;117:24384-24391.
    PubMed     Abstract available


  158. RABE BA, Cepko C
    SARS-CoV-2 detection using isothermal amplification and a rapid, inexpensive protocol for sample inactivation and purification.
    Proc Natl Acad Sci U S A. 2020;117:24450-24458.
    PubMed     Abstract available


  159. KARATAYEV VA, Anand M, Bauch CT
    Local lockdowns outperform global lockdown on the far side of the COVID-19 epidemic curve.
    Proc Natl Acad Sci U S A. 2020;117:24575-24580.
    PubMed     Abstract available


  160. LINDESTAM ARLEHAMN CS, Sette A, Peters B
    Lack of evidence for BCG vaccine protection from severe COVID-19.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2016733117.
    PubMed    


  161. PATELLA V, Delfino G, Bruzzese D, Giuliano A, et al
    The bacillus Calmette-Guerin vaccination allows the innate immune system to provide protection from severe COVID-19 infection.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2015234117.
    PubMed    


  162. BARILLAS-MURY C, Escobar LE, Molina-Cruz A
    Reply to Patella et al. and Lindestam Arlehamn et al.: Complex pandemic dynamics and effect of bacillus Calmette-Guerin (BCG) vaccination on COVID-19 prevalence and mortality.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2017197117.
    PubMed    


  163. MALISCH JL, Harris BN, Sherrer SM, Lewis KA, et al
    Reply to Arora et al.: Concerns and considerations about using the CV as an equity tool.
    Proc Natl Acad Sci U S A. 2020;117:24033-24034.
    PubMed    


  164. LIONG S, Oseghale O, To EE, Brassington K, et al
    Influenza A virus causes maternal and fetal pathology via innate and adaptive vascular inflammation in mice.
    Proc Natl Acad Sci U S A. 2020 Sep 21. pii: 2006905117.
    PubMed     Abstract available


  165. RAUSCH JW, Capoferri AA, Katusiime MG, Patro SC, et al
    Low genetic diversity may be an Achilles heel of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2020 Sep 21. pii: 2017726117.
    PubMed    


  166. GANGULI A, Mostafa A, Berger J, Aydin MY, et al
    Rapid isothermal amplification and portable detection system for SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2020;117:22727-22735.
    PubMed     Abstract available


  167. THURNER S, Klimek P, Hanel R
    A network-based explanation of why most COVID-19 infection curves are linear.
    Proc Natl Acad Sci U S A. 2020;117:22684-22689.
    PubMed     Abstract available



  168. Correction to Supporting Information for Sun et al., Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection.
    Proc Natl Acad Sci U S A. 2020 Sep 8. pii: 2017619117.
    PubMed    


  169. WRIGLEY-FIELD E
    US racial inequality may be as deadly as COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:21854-21856.
    PubMed     Abstract available


  170. DAMAS J, Hughes GM, Keough KC, Painter CA, et al
    Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates.
    Proc Natl Acad Sci U S A. 2020;117:22311-22322.
    PubMed     Abstract available


  171. PERKINS TA, Cavany SM, Moore SM, Oidtman RJ, et al
    Estimating unobserved SARS-CoV-2 infections in the United States.
    Proc Natl Acad Sci U S A. 2020;117:22597-22602.
    PubMed     Abstract available


  172. KANG S, Tanaka T, Inoue H, Ono C, et al
    IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
    Proc Natl Acad Sci U S A. 2020;117:22351-22356.
    PubMed     Abstract available


  173. BETSCH C, Korn L, Sprengholz P, Felgendreff L, et al
    Social and behavioral consequences of mask policies during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2020;117:21851-21853.
    PubMed     Abstract available


  174. KIM E, Shepherd ME, Clinton JD
    The effect of big-city news on rural America during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2020;117:22009-22014.
    PubMed     Abstract available


  175. LAU MSY, Grenfell B, Thomas M, Bryan M, et al
    Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA.
    Proc Natl Acad Sci U S A. 2020;117:22430-22435.
    PubMed     Abstract available


  176. LIU WJ, Li J, Zou R, Pan J, et al
    Dynamic PB2-E627K substitution of influenza H7N9 virus indicates the in vivo genetic tuning and rapid host adaptation.
    Proc Natl Acad Sci U S A. 2020 Sep 1. pii: 2013267117.
    PubMed     Abstract available


  177. SEBHATU A, Wennberg K, Arora-Jonsson S, Lindberg SI, et al
    Explaining the homogeneous diffusion of COVID-19 nonpharmaceutical interventions across heterogeneous countries.
    Proc Natl Acad Sci U S A. 2020;117:21201-21208.
    PubMed     Abstract available


    August 2020
  178. DEARLOVE B, Lewitus E, Bai H, Li Y, et al
    A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.
    Proc Natl Acad Sci U S A. 2020 Aug 31. pii: 2008281117.
    PubMed     Abstract available


  179. KANG YL, Chou YY, Rothlauf PW, Liu Z, et al
    Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2020;117:20803-20813.
    PubMed     Abstract available


  180. SHERIDAN A, Andersen AL, Hansen ET, Johannesen N, et al
    Social distancing laws cause only small losses of economic activity during the COVID-19 pandemic in Scandinavia.
    Proc Natl Acad Sci U S A. 2020;117:20468-20473.
    PubMed     Abstract available


  181. GOLDSTEIN JR, Lee RD
    Demographic perspectives on the mortality of COVID-19 and other epidemics.
    Proc Natl Acad Sci U S A. 2020 Aug 20. pii: 2006392117.
    PubMed     Abstract available


  182. HOLTZ D, Zhao M, Benzell SG, Cao CY, et al
    Interdependence and the cost of uncoordinated responses to COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:19837-19843.
    PubMed     Abstract available


  183. WEILL JA, Stigler M, Deschenes O, Springborn MR, et al
    Social distancing responses to COVID-19 emergency declarations strongly differentiated by income.
    Proc Natl Acad Sci U S A. 2020;117:19658-19660.
    PubMed     Abstract available


  184. DUQUE D, Morton DP, Singh B, Du Z, et al
    Timing social distancing to avert unmanageable COVID-19 hospital surges.
    Proc Natl Acad Sci U S A. 2020;117:19873-19878.
    PubMed     Abstract available


  185. OMARY MB, Hassan M
    Opinion: Here's how we restore productivity and vigor to the biomedical research workforce in the midst of COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:19612-19614.
    PubMed    


  186. SEKIZUKA T, Itokawa K, Kageyama T, Saito S, et al
    Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak.
    Proc Natl Acad Sci U S A. 2020;117:20198-20201.
    PubMed     Abstract available


  187. VENTER ZS, Aunan K, Chowdhury S, Lelieveld J, et al
    COVID-19 lockdowns cause global air pollution declines.
    Proc Natl Acad Sci U S A. 2020;117:18984-18990.
    PubMed     Abstract available


  188. ARPINO B, Bordone V, Pasqualini M
    No clear association emerges between intergenerational relationships and COVID-19 fatality rates from macro-level analyses.
    Proc Natl Acad Sci U S A. 2020;117:19116-19121.
    PubMed     Abstract available


  189. CAUCHOIS R, Koubi M, Delarbre D, Manet C, et al
    Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:18951-18953.
    PubMed     Abstract available


  190. HAMER M, Gale CR, Kivimaki M, Batty GD, et al
    Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom.
    Proc Natl Acad Sci U S A. 2020 Aug 11. pii: 2011086117.
    PubMed     Abstract available


  191. LYCETT SJ, Pohlmann A, Staubach C, Caliendo V, et al
    Genesis and spread of multiple reassortants during the 2016/2017 H5 avian influenza epidemic in Eurasia.
    Proc Natl Acad Sci U S A. 2020 Aug 7. pii: 2001813117.
    PubMed     Abstract available


  192. HRABOWSKI FA 3RD, Tracy JK, Henderson PH
    Opinion: At a Crossroads: Reimagining science, engineering, and medicine-and its practitioners.
    Proc Natl Acad Sci U S A. 2020;117:18137-18141.
    PubMed    


    July 2020
  193. BARTIK AW, Bertrand M, Cullen Z, Glaeser EL, et al
    The impact of COVID-19 on small business outcomes and expectations.
    Proc Natl Acad Sci U S A. 2020;117:17656-17666.
    PubMed     Abstract available


  194. XIE W, Campbell S, Zhang W
    Working memory capacity predicts individual differences in social-distancing compliance during the COVID-19 pandemic in the United States.
    Proc Natl Acad Sci U S A. 2020;117:17667-17674.
    PubMed     Abstract available


  195. VERDERY AM, Smith-Greenaway E, Margolis R, Daw J, et al
    Tracking the reach of COVID-19 kin loss with a bereavement multiplier applied to the United States.
    Proc Natl Acad Sci U S A. 2020;117:17695-17701.
    PubMed     Abstract available


  196. MOGHADAS SM, Fitzpatrick MC, Sah P, Pandey A, et al
    The implications of silent transmission for the control of COVID-19 outbreaks.
    Proc Natl Acad Sci U S A. 2020;117:17513-17515.
    PubMed     Abstract available


  197. EYAL N, Lipsitch M
    Opinion: It's ethical to test promising coronavirus vaccines against less-promising ones.
    Proc Natl Acad Sci U S A. 2020 Jul 22. pii: 2014154117.
    PubMed    


  198. BERTOZZI AL, Franco E, Mohler G, Short MB, et al
    The challenges of modeling and forecasting the spread of COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:16732-16738.
    PubMed     Abstract available


  199. YAO Y, Kadam RU, Lee CD, Woehl JL, et al
    An influenza A hemagglutinin small-molecule fusion inhibitor identified by a new high-throughput fluorescence polarization screen.
    Proc Natl Acad Sci U S A. 2020 Jul 20. pii: 2006893117.
    PubMed     Abstract available


  200. LIAO HY, Wang SC, Ko YA, Lin KI, et al
    Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes.
    Proc Natl Acad Sci U S A. 2020 Jul 15. pii: 2004783117.
    PubMed     Abstract available


  201. SIEGENFELD AF, Taleb NN, Bar-Yam Y
    Opinion: What models can and cannot tell us about COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:16092-16095.
    PubMed    


  202. LAMMERS J, Crusius J, Gast A
    Correcting misperceptions of exponential coronavirus growth increases support for social distancing.
    Proc Natl Acad Sci U S A. 2020;117:16264-16266.
    PubMed     Abstract available


  203. ESTEVE A, Permanyer I, Boertien D, Vaupel JW, et al
    National age and coresidence patterns shape COVID-19 vulnerability.
    Proc Natl Acad Sci U S A. 2020;117:16118-16120.
    PubMed     Abstract available


  204. IMAI M, Iwatsuki-Horimoto K, Hatta M, Loeber S, et al
    Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
    Proc Natl Acad Sci U S A. 2020;117:16587-16595.
    PubMed     Abstract available


  205. ELLEBEDY AH, Nachbagauer R, Jackson KJL, Dai YN, et al
    Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans.
    Proc Natl Acad Sci U S A. 2020 Jul 13. pii: 1906613117.
    PubMed     Abstract available


  206. ESCOBAR LE, Molina-Cruz A, Barillas-Mury C
    BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).
    Proc Natl Acad Sci U S A. 2020 Jul 9. pii: 2008410117.
    PubMed     Abstract available


  207. BONACCORSI G, Pierri F, Cinelli M, Flori A, et al
    Economic and social consequences of human mobility restrictions under COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:15530-15535.
    PubMed     Abstract available


  208. MALISCH JL, Harris BN, Sherrer SM, Lewis KA, et al
    Opinion: In the wake of COVID-19, academia needs new solutions to ensure gender equity.
    Proc Natl Acad Sci U S A. 2020;117:15378-15381.
    PubMed    


  209. TAM VC, Suen R, Treuting PM, Armando A, et al
    PPARalpha exacerbates necroptosis, leading to increased mortality in postinfluenza bacterial superinfection.
    Proc Natl Acad Sci U S A. 2020;117:15789-15798.
    PubMed     Abstract available


  210. AREVALO CP, Le Sage V, Bolton MJ, Eilola T, et al
    Original antigenic sin priming of influenza virus hemagglutinin stalk antibodies.
    Proc Natl Acad Sci U S A. 2020 Jul 6. pii: 1920321117.
    PubMed     Abstract available


  211. MULLER NF, Stolz U, Dudas G, Stadler T, et al
    Bayesian inference of reassortment networks reveals fitness benefits of reassortment in human influenza viruses.
    Proc Natl Acad Sci U S A. 2020 Jul 6. pii: 1918304117.
    PubMed     Abstract available


    June 2020
  212. ZHANG R, Li Y, Zhang AL, Wang Y, et al
    Identifying airborne transmission as the dominant route for the spread of COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:14857-14863.
    PubMed     Abstract available


  213. BENZELL SG, Collis A, Nicolaides C
    Rationing social contact during the COVID-19 pandemic: Transmission risk and social benefits of US locations.
    Proc Natl Acad Sci U S A. 2020;117:14642-14644.
    PubMed     Abstract available


  214. SUN H, Xiao Y, Liu J, Wang D, et al
    Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection.
    Proc Natl Acad Sci U S A. 2020 Jun 29. pii: 1921186117.
    PubMed     Abstract available


  215. SCHREIBER A, Boff L, Anhlan D, Krischuns T, et al
    Dissecting the mechanism of signaling-triggered nuclear export of newly synthesized influenza virus ribonucleoprotein complexes.
    Proc Natl Acad Sci U S A. 2020 Jun 29. pii: 2002828117.
    PubMed     Abstract available


  216. DOWD JB, Andriano L, Brazel DM, Rotondi V, et al
    Reply to Nepomuceno et al.: A renewed call for detailed social and demographic COVID-19 data from all countries.
    Proc Natl Acad Sci U S A. 2020;117:13884-13885.
    PubMed    


  217. NEPOMUCENO MR, Acosta E, Alburez-Gutierrez D, Aburto JM, et al
    Besides population age structure, health and other demographic factors can contribute to understanding the COVID-19 burden.
    Proc Natl Acad Sci U S A. 2020;117:13881-13883.
    PubMed    


  218. WANG Y, Liu M, Gao J
    Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions.
    Proc Natl Acad Sci U S A. 2020;117:13967-13974.
    PubMed     Abstract available


  219. CEBALLOS G, Ehrlich PR, Raven PH
    Vertebrates on the brink as indicators of biological annihilation and the sixth mass extinction.
    Proc Natl Acad Sci U S A. 2020;117:13596-13602.
    PubMed     Abstract available


  220. FORSTER P, Forster L, Renfrew C, Forster M, et al
    Reply to Sanchez-Pacheco et al., Chookajorn, and Mavian et al.: Explaining phylogenetic network analysis of SARS-CoV-2 genomes.
    Proc Natl Acad Sci U S A. 2020;117:12524-12525.
    PubMed    


  221. RAKER EJ, Zacher M, Lowe SR
    Lessons from Hurricane Katrina for predicting the indirect health consequences of the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2020;117:12595-12597.
    PubMed     Abstract available


  222. ZENG F, Chen X, Deng G
    Convalescent plasma for patients with COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:12528.
    PubMed    


  223. KESICI S, Yavuz S, Bayrakci B
    Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:12526-12527.
    PubMed    


  224. DUAN K, Liu B, Li C, Zhang H, et al
    Reply to Kesici et al. and Zeng et al.: Blocking the virus and reducing the inflammatory damage in COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:12529-12530.
    PubMed    


  225. CHOOKAJORN T
    Evolving COVID-19 conundrum and its impact.
    Proc Natl Acad Sci U S A. 2020;117:12520-12521.
    PubMed    


  226. MAVIAN C, Pond SK, Marini S, Magalis BR, et al
    Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable.
    Proc Natl Acad Sci U S A. 2020;117:12522-12523.
    PubMed    


  227. SANCHEZ-PACHECO SJ, Kong S, Pulido-Santacruz P, Murphy RW, et al
    Median-joining network analysis of SARS-CoV-2 genomes is neither phylogenetic nor evolutionary.
    Proc Natl Acad Sci U S A. 2020;117:12518-12519.
    PubMed    


  228. STADNYTSKYI V, Bax CE, Bax A, Anfinrud P, et al
    The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission.
    Proc Natl Acad Sci U S A. 2020;117:11875-11877.
    PubMed     Abstract available


    May 2020
  229. DELAVERIS CS, Webster ER, Banik SM, Boxer SG, et al
    Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus.
    Proc Natl Acad Sci U S A. 2020 May 26. pii: 1921962117.
    PubMed     Abstract available


  230. BENTO AI, Nguyen T, Wing C, Lozano-Rojas F, et al
    Evidence from internet search data shows information-seeking responses to news of local COVID-19 cases.
    Proc Natl Acad Sci U S A. 2020;117:11220-11222.
    PubMed     Abstract available


  231. REILLY EC, Lambert Emo K, Buckley PM, Reilly NS, et al
    TRM integrins CD103 and CD49a differentially support adherence and motility after resolution of influenza virus infection.
    Proc Natl Acad Sci U S A. 2020 May 21. pii: 1915681117.
    PubMed     Abstract available


  232. XU X, Han M, Li T, Sun W, et al
    Effective treatment of severe COVID-19 patients with tocilizumab.
    Proc Natl Acad Sci U S A. 2020;117:10970-10975.
    PubMed     Abstract available


  233. MADHUSOODANAN J
    News Feature: To counter the pandemic, clinicians bank on repurposed drugs.
    Proc Natl Acad Sci U S A. 2020;117:10616-10620.
    PubMed    


  234. GATTO M, Bertuzzo E, Mari L, Miccoli S, et al
    Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures.
    Proc Natl Acad Sci U S A. 2020;117:10484-10491.
    PubMed     Abstract available


  235. DOWD JB, Andriano L, Brazel DM, Rotondi V, et al
    Demographic science aids in understanding the spread and fatality rates of COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:9696-9698.
    PubMed     Abstract available


  236. MCDERMOTT A
    Inner Workings: Molecular biologists offer "wartime service" in the effort to test for COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:9656-9659.
    PubMed    


    April 2020
  237. FORSTER P, Forster L, Renfrew C, Forster M, et al
    Phylogenetic network analysis of SARS-CoV-2 genomes.
    Proc Natl Acad Sci U S A. 2020;117:9241-9243.
    PubMed     Abstract available


  238. DUAN K, Liu B, Li C, Zhang H, et al
    Effectiveness of convalescent plasma therapy in severe COVID-19 patients.
    Proc Natl Acad Sci U S A. 2020;117:9490-9496.
    PubMed     Abstract available


  239. MOGHADAS SM, Shoukat A, Fitzpatrick MC, Wells CR, et al
    Projecting hospital utilization during the COVID-19 outbreaks in the United States.
    Proc Natl Acad Sci U S A. 2020;117:9122-9126.
    PubMed     Abstract available


    March 2020
  240. WELLS CR, Sah P, Moghadas SM, Pandey A, et al
    Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak.
    Proc Natl Acad Sci U S A. 2020;117:7504-7509.
    PubMed     Abstract available


  241. MATSUYAMA S, Nao N, Shirato K, Kawase M, et al
    Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
    Proc Natl Acad Sci U S A. 2020;117:7001-7003.
    PubMed     Abstract available


  242. PEEPLES L
    News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.
    Proc Natl Acad Sci U S A. 2020 Mar 30. pii: 2005456117.
    PubMed    


  243. JONES JC, Pascua PNQ, Fabrizio TP, Marathe BM, et al
    Influenza A and B viruses with reduced baloxavir susceptibility display attenuated in vitro fitness but retain ferret transmissibility.
    Proc Natl Acad Sci U S A. 2020 Mar 26. pii: 1916825117.
    PubMed     Abstract available


  244. DE WIT E, Feldmann F, Cronin J, Jordan R, et al
    Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proc Natl Acad Sci U S A. 2020;117:6771-6776.
    PubMed     Abstract available


  245. PABIS A, Rawle RJ, Kasson PM
    Influenza hemagglutinin drives viral entry via two sequential intramembrane mechanisms.
    Proc Natl Acad Sci U S A. 2020 Mar 18. pii: 1914188117.
    PubMed     Abstract available


  246. CHO JH, Zhao B, Shi J, Savage N, et al
    Molecular recognition of a host protein by NS1 of pandemic and seasonal influenza A viruses.
    Proc Natl Acad Sci U S A. 2020 Mar 9. pii: 1920582117.
    PubMed     Abstract available


  247. MARREIROS R, Muller-Schiffmann A, Trossbach SV, Prikulis I, et al
    Disruption of cellular proteostasis by H1N1 influenza A virus causes alpha-synuclein aggregation.
    Proc Natl Acad Sci U S A. 2020 Mar 9. pii: 1906466117.
    PubMed     Abstract available


  248. KLOEPFER KM, Gern JE
    Ecological and individual data both indicate that influenza inhibits rhinovirus infection.
    Proc Natl Acad Sci U S A. 2020 Mar 3. pii: 1922920117.
    PubMed    


  249. NICKBAKHSH S, Mair C, Matthews L, Reeve R, et al
    Reply to Kloepfer and Gern: Independent studies suggest an arms race between influenza and rhinovirus: What next?
    Proc Natl Acad Sci U S A. 2020 Mar 3. pii: 2000903117.
    PubMed    


  250. YANG Q, Zhao X, Lemey P, Suchard MA, et al
    Assessing the role of live poultry trade in community-structured transmission of avian influenza in China.
    Proc Natl Acad Sci U S A. 2020 Mar 2. pii: 1906954117.
    PubMed     Abstract available


    February 2020
  251. TORABIFARD H, Panahi A, Brooks CL 3rd
    M2 amphipathic helices facilitate pH-dependent conformational transition in influenza A virus.
    Proc Natl Acad Sci U S A. 2020 Feb 3. pii: 1913385117.
    PubMed     Abstract available


    January 2020
  252. NEWMAN JH, Chesson CB, Herzog NL, Bommareddy PK, et al
    Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer.
    Proc Natl Acad Sci U S A. 2020;117:1119-1128.
    PubMed     Abstract available


  253. YEH YT, Gulino K, Zhang Y, Sabestien A, et al
    A rapid and label-free platform for virus capture and identification from clinical samples.
    Proc Natl Acad Sci U S A. 2020;117:895-901.
    PubMed     Abstract available


  254. COVES-DATSON EM, King SR, Legendre M, Gupta A, et al
    A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo.
    Proc Natl Acad Sci U S A. 2020 Jan 13. pii: 1915152117.
    PubMed     Abstract available


    December 2019
  255. MCCARTHY KR, Raymond DD, Do KT, Schmidt AG, et al
    Affinity maturation in a human humoral response to influenza hemagglutinin.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1915620116.
    PubMed     Abstract available


  256. VIRK RK, Jayakumar J, Mendenhall IH, Moorthy M, et al
    Divergent evolutionary trajectories of influenza B viruses underlie their contemporaneous epidemic activity.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1916585116.
    PubMed     Abstract available


  257. NICKBAKHSH S, Mair C, Matthews L, Reeve R, et al
    Virus-virus interactions impact the population dynamics of influenza and the common cold.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1911083116.
    PubMed     Abstract available


    October 2019

  258. Correction for Sah et al., Future epidemiological and economic impacts of universal influenza vaccines.
    Proc Natl Acad Sci U S A. 2019 Oct 21. pii: 1917260116.
    PubMed    


  259. BRACHER J
    On the multibin logarithmic score used in the FluSight competitions.
    Proc Natl Acad Sci U S A. 2019;116:20809-20810.
    PubMed    


  260. REICH NG, Osthus D, Ray EL, Yamana TK, et al
    Reply to Bracher: Scoring probabilistic forecasts to maximize public health interpretability.
    Proc Natl Acad Sci U S A. 2019;116:20811-20812.
    PubMed    


  261. POPOVA AV, Safina KR, Ptushenko VV, Stolyarova AV, et al
    Allele-specific nonstationarity in evolution of influenza A virus surface proteins.
    Proc Natl Acad Sci U S A. 2019 Oct 2. pii: 1904246116.
    PubMed     Abstract available


    September 2019
  262. SAH P, Alfaro-Murillo JA, Fitzpatrick MC, Neuzil KM, et al
    Future epidemiological and economic impacts of universal influenza vaccines.
    Proc Natl Acad Sci U S A. 2019 Sep 23. pii: 1909613116.
    PubMed     Abstract available


    August 2019
  263. KENNEY AD, McMichael TM, Imas A, Chesarino NM, et al
    IFITM3 protects the heart during influenza virus infection.
    Proc Natl Acad Sci U S A. 2019 Aug 26. pii: 1900784116.
    PubMed     Abstract available


  264. SCHMIDT N, Domingues P, Golebiowski F, Patzina C, et al
    An influenza virus-triggered SUMO switch orchestrates co-opted endogenous retroviruses to stimulate host antiviral immunity.
    Proc Natl Acad Sci U S A. 2019 Aug 7. pii: 1907031116.
    PubMed     Abstract available


    July 2019
  265. WINARSKI KL, Tang J, Klenow L, Lee J, et al
    Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics.
    Proc Natl Acad Sci U S A. 2019 Jul 11. pii: 1821317116.
    PubMed     Abstract available


    June 2019
  266. LITVINOVA M, Liu QH, Kulikov ES, Ajelli M, et al
    Reactive school closure weakens the network of social interactions and reduces the spread of influenza.
    Proc Natl Acad Sci U S A. 2019 Jun 17. pii: 1821298116.
    PubMed     Abstract available


    May 2019
  267. ZHU B, Zhang R, Li C, Jiang L, et al
    BCL6 modulates tissue neutrophil survival and exacerbates pulmonary inflammation following influenza virus infection.
    Proc Natl Acad Sci U S A. 2019 May 28. pii: 1902310116.
    PubMed     Abstract available


  268. DE GREEF JC, Slutter B, Anderson ME, Hamlyn R, et al
    Protective role for the N-terminal domain of alpha-dystroglycan in Influenza A virus proliferation.
    Proc Natl Acad Sci U S A. 2019 May 16. pii: 1904493116.
    PubMed     Abstract available


  269. KUDO E, Song E, Yockey LJ, Rakib T, et al
    Low ambient humidity impairs barrier function and innate resistance against influenza infection.
    Proc Natl Acad Sci U S A. 2019 May 13. pii: 1902840116.
    PubMed     Abstract available


    April 2019
  270. MASLANKA FIGUEROA S, Veser A, Abstiens K, Fleischmann D, et al
    Influenza A virus mimetic nanoparticles trigger selective cell uptake.
    Proc Natl Acad Sci U S A. 2019 Apr 29. pii: 1902563116.
    PubMed     Abstract available


    February 2019
  271. CULLEN JG, McQuilten HA, Quinn KM, Olshansky M, et al
    CD4(+) T help promotes influenza virus-specific CD8(+) T cell memory by limiting metabolic dysfunction.
    Proc Natl Acad Sci U S A. 2019 Feb 20. pii: 1808849116.
    PubMed     Abstract available


  272. TSENG YC, Wu CY, Liu ML, Chen TH, et al
    Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections.
    Proc Natl Acad Sci U S A. 2019 Feb 19. pii: 1819197116.
    PubMed     Abstract available


  273. WHITE MC, Tao H, Steel J, Lowen AC, et al
    H5N8 and H7N9 packaging signals constrain HA reassortment with a seasonal H3N2 influenza A virus.
    Proc Natl Acad Sci U S A. 2019 Feb 13. pii: 1818494116.
    PubMed     Abstract available


  274. VIBOUD C, Vespignani A
    The future of influenza forecasts.
    Proc Natl Acad Sci U S A. 2019 Feb 8. pii: 1822167116.
    PubMed    


  275. MORIYAMA M, Ichinohe T
    High ambient temperature dampens adaptive immune responses to influenza A virus infection.
    Proc Natl Acad Sci U S A. 2019 Feb 4. pii: 1815029116.
    PubMed     Abstract available


    January 2019
  276. YAMAUCHI Y
    Quantum dots crack the influenza uncoating puzzle.
    Proc Natl Acad Sci U S A. 2019 Jan 31. pii: 1822089116.
    PubMed    


  277. REICH NG, Brooks LC, Fox SJ, Kandula S, et al
    A collaborative multiyear, multimodel assessment of seasonal influenza forecasting in the United States.
    Proc Natl Acad Sci U S A. 2019 Jan 15. pii: 1812594116.
    PubMed     Abstract available


  278. SEVY AM, Wu NC, Gilchuk IM, Parrish EH, et al
    Multistate design of influenza antibodies improves affinity and breadth against seasonal viruses.
    Proc Natl Acad Sci U S A. 2019 Jan 14. pii: 1806004116.
    PubMed     Abstract available


  279. QIN C, Li W, Li Q, Yin W, et al
    Real-time dissection of dynamic uncoating of individual influenza viruses.
    Proc Natl Acad Sci U S A. 2019 Jan 9. pii: 1812632116.
    PubMed     Abstract available


    December 2018
  280. FURUSE Y
    Analysis of research intensity on infectious disease by disease burden reveals which infectious diseases are neglected by researchers.
    Proc Natl Acad Sci U S A. 2018 Dec 31. pii: 1814484116.
    PubMed     Abstract available


  281. ZHANG K, Shang G, Padavannil A, Wang J, et al
    Structural-functional interactions of NS1-BP protein with the splicing and mRNA export machineries for viral and host gene expression.
    Proc Natl Acad Sci U S A. 2018;115:E12218-E12227.
    PubMed     Abstract available


  282. LUO G, Ambati A, Lin L, Bonvalet M, et al
    Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy.
    Proc Natl Acad Sci U S A. 2018 Dec 12. pii: 1818150116.
    PubMed     Abstract available


  283. LIU QH, Ajelli M, Aleta A, Merler S, et al
    Measurability of the epidemic reproduction number in data-driven contact networks.
    Proc Natl Acad Sci U S A. 2018;115:12680-12685.
    PubMed     Abstract available


    November 2018
  284. FINK AL, Engle K, Ursin RL, Tang WY, et al
    Biological sex affects vaccine efficacy and protection against influenza in mice.
    Proc Natl Acad Sci U S A. 2018 Nov 19. pii: 1805268115.
    PubMed     Abstract available


  285. STEWART-JONES GBE, Chuang GY, Xu K, Zhou T, et al
    Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4.
    Proc Natl Acad Sci U S A. 2018 Nov 12. pii: 1811980115.
    PubMed     Abstract available


    October 2018
  286. GOLDHILL DH, Te Velthuis AJW, Fletcher RA, Langat P, et al
    The mechanism of resistance to favipiravir in influenza.
    Proc Natl Acad Sci U S A. 2018 Oct 23. pii: 1811345115.
    PubMed     Abstract available


    September 2018
  287. BENTON DJ, Nans A, Calder LJ, Turner J, et al
    Influenza hemagglutinin membrane anchor.
    Proc Natl Acad Sci U S A. 2018 Sep 17. pii: 1810927115.
    PubMed     Abstract available


  288. SJAASTAD LE, Fay EJ, Fiege JK, Macchietto MG, et al
    Distinct antiviral signatures revealed by the magnitude and round of influenza virus replication in vivo.
    Proc Natl Acad Sci U S A. 2018 Sep 4. pii: 1807516115.
    PubMed     Abstract available


    August 2018
  289. MADSEN JJ, Grime JMA, Rossman JS, Voth GA, et al
    Entropic forces drive clustering and spatial localization of influenza A M2 during viral budding.
    Proc Natl Acad Sci U S A. 2018 Aug 27. pii: 1805443115.
    PubMed     Abstract available


  290. LEE JM, Huddleston J, Doud MB, Hooper KA, et al
    Deep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 influenza variants.
    Proc Natl Acad Sci U S A. 2018 Aug 13. pii: 1806133115.
    PubMed     Abstract available


    July 2018
  291. DENG L, Chang TZ, Wang Y, Li S, et al
    Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice.
    Proc Natl Acad Sci U S A. 2018 Jul 31. pii: 1805713115.
    PubMed     Abstract available


  292. GUALDONI GA, Mayer KA, Kapsch AM, Kreuzberg K, et al
    Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replication.
    Proc Natl Acad Sci U S A. 2018;115:E7158-E7165.
    PubMed     Abstract available


  293. LIN X, Noel JK, Wang Q, Ma J, et al
    Atomistic simulations indicate the functional loop-to-coiled-coil transition in influenza hemagglutinin is not downhill.
    Proc Natl Acad Sci U S A. 2018 Jul 16. pii: 1805442115.
    PubMed     Abstract available


    June 2018
  294. UEKI H, Wang IH, Fukuyama S, Katsura H, et al
    In vivo imaging of the pathophysiological changes and neutrophil dynamics in influenza virus-infected mouse lungs.
    Proc Natl Acad Sci U S A. 2018 Jun 25. pii: 1806265115.
    PubMed     Abstract available


  295. ZHOU J, Li C, Sachs N, Chiu MC, et al
    Differentiated human airway organoids to assess infectivity of emerging influenza virus.
    Proc Natl Acad Sci U S A. 2018 Jun 11. pii: 1806308115.
    PubMed     Abstract available


    April 2018
  296. SAH P, Medlock J, Fitzpatrick MC, Singer BH, et al
    Optimizing the impact of low-efficacy influenza vaccines.
    Proc Natl Acad Sci U S A. 2018 Apr 30. pii: 1802479115.
    PubMed     Abstract available


  297. KADAM RU, Wilson IA
    A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin.
    Proc Natl Acad Sci U S A. 2018 Apr 2. pii: 1801999115.
    PubMed     Abstract available


    February 2018
  298. PEI S, Kandula S, Yang W, Shaman J, et al
    Forecasting the spatial transmission of influenza in the United States.
    Proc Natl Acad Sci U S A. 2018 Feb 26. pii: 1708856115.
    PubMed     Abstract available


  299. ZHOU J, Wei J, Choy KT, Sia SF, et al
    Defining the sizes of airborne particles that mediate influenza transmission in ferrets.
    Proc Natl Acad Sci U S A. 2018 Feb 20. pii: 1716771115.
    PubMed     Abstract available


    January 2018
  300. YAN J, Grantham M, Pantelic J, Bueno de Mesquita PJ, et al
    Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community.
    Proc Natl Acad Sci U S A. 2018 Jan 18. pii: 1716561115.
    PubMed     Abstract available


  301. MENACHERY VD, Schafer A, Burnum-Johnson KE, Mitchell HD, et al
    MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape.
    Proc Natl Acad Sci U S A. 2018 Jan 16. pii: 1706928115.
    PubMed     Abstract available


    December 2017
  302. RAYMOND DD, Bajic G, Ferdman J, Suphaphiphat P, et al
    Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody.
    Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1715471115.
    PubMed     Abstract available


    November 2017
  303. ELKINS MR, Williams JK, Gelenter MD, Dai P, et al
    Cholesterol-binding site of the influenza M2 protein in lipid bilayers from solid-state NMR.
    Proc Natl Acad Sci U S A. 2017 Nov 20. pii: 201715127.
    PubMed     Abstract available


  304. ZOST SJ, Parkhouse K, Gumina ME, Kim K, et al
    Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Proc Natl Acad Sci U S A. 2017 Nov 6. pii: 201712377.
    PubMed     Abstract available


    September 2017
  305. ZANIN M, Wong SS, Barman S, Kaewborisuth C, et al
    Molecular basis of mammalian transmissibility of avian H1N1 influenza viruses and their pandemic potential.
    Proc Natl Acad Sci U S A. 2017 Sep 5. pii: 201713974.
    PubMed     Abstract available


  306. MAAMARY J, Wang TT, Tan GS, Palese P, et al
    Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization.
    Proc Natl Acad Sci U S A. 2017 Sep 5. pii: 201707950.
    PubMed     Abstract available


    August 2017
  307. THOMASTON JL, Woldeyes RA, Nakane T, Yamashita A, et al
    XFEL structures of the influenza M2 proton channel: Room temperature water networks and insights into proton conduction.
    Proc Natl Acad Sci U S A. 2017 Aug 23. pii: 201705624.
    PubMed     Abstract available


    July 2017
  308. NIKOLAIDIS NM, Noel JG, Pitstick LB, Gardner JC, et al
    Mitogenic stimulation accelerates influenza-induced mortality by increasing susceptibility of alveolar type II cells to infection.
    Proc Natl Acad Sci U S A. 2017 Jul 24. pii: 201621172.
    PubMed     Abstract available


  309. ASGARI S, Schlapbach LJ, Anchisi S, Hammer C, et al
    Severe viral respiratory infections in children with IFIH1 loss-of-function mutations.
    Proc Natl Acad Sci U S A. 2017 Jul 17. pii: 201704259.
    PubMed     Abstract available


  310. BLACKMORE S, Hernandez J, Juda M, Ryder E, et al
    Influenza infection triggers disease in a genetic model of experimental autoimmune encephalomyelitis.
    Proc Natl Acad Sci U S A. 2017 Jul 10. pii: 201620415.
    PubMed     Abstract available


    May 2017
  311. PIZZOLLA A, Wang Z, Groom JR, Kedzierska K, et al
    Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells.
    Proc Natl Acad Sci U S A. 2017 May 1. pii: 201620194.
    PubMed     Abstract available


    April 2017
  312. XIE J, Sok D, Wu NC, Zheng T, et al
    Immunochemical engineering of cell surfaces to generate virus resistance.
    Proc Natl Acad Sci U S A. 2017 Apr 10. pii: 201702764.
    PubMed     Abstract available


  313. SHANKS GD, Brundage JF
    Variable mortality during the 1918 influenza pandemic in Chicago.
    Proc Natl Acad Sci U S A. 2017 Apr 6. pii: 201701344.
    PubMed    


    March 2017
  314. BASKERVILLE EB, Cobey S
    Does influenza drive absolute humidity?
    Proc Natl Acad Sci U S A. 2017 Mar 15. pii: 201700369.
    PubMed    


    February 2017
  315. KREMENTSOV DN, Case LK, Dienz O, Raza A, et al
    Genetic variation in chromosome Y regulates susceptibility to influenza A virus infection.
    Proc Natl Acad Sci U S A. 2017 Feb 27. pii: 201620889.
    PubMed     Abstract available


    December 2016
  316. WU CY, Lin CW, Tsai TI, Lee CD, et al
    Influenza A surface glycosylation and vaccine design.
    Proc Natl Acad Sci U S A. 2016 Dec 27. pii: 201617174.
    PubMed     Abstract available


  317. KADAM RU, Wilson IA
    Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol.
    Proc Natl Acad Sci U S A. 2016 Dec 21. pii: 201617020.
    PubMed     Abstract available


  318. PING J, Lopes TJ, Neumann G, Kawaoka Y, et al
    Development of high-yield influenza B virus vaccine viruses.
    Proc Natl Acad Sci U S A. 2016 Dec 5. pii: 201616530.
    PubMed     Abstract available


    November 2016
  319. CHOWELL G, Viboud C
    Pandemic influenza and socioeconomic disparities: Lessons from 1918 Chicago.
    Proc Natl Acad Sci U S A. 2016;113:13557-13559.
    PubMed    


  320. GRANTZ KH, Rane MS, Salje H, Glass GE, et al
    Disparities in influenza mortality and transmission related to sociodemographic factors within Chicago in the pandemic of 1918.
    Proc Natl Acad Sci U S A. 2016 Nov 21. pii: 201612838.
    PubMed     Abstract available


  321. BJORNSTAD ON, Viboud C
    Timing and periodicity of influenza epidemics.
    Proc Natl Acad Sci U S A. 2016 Nov 3. pii: 201616052.
    PubMed    


    October 2016
  322. DEYLE ER, Maher MC, Hernandez RD, Basu S, et al
    Global environmental drivers of influenza.
    Proc Natl Acad Sci U S A. 2016 Oct 31. pii: 201607747.
    PubMed     Abstract available


  323. YAMIN D, Jones FK, DeVincenzo JP, Gertler S, et al
    Vaccination strategies against respiratory syncytial virus.
    Proc Natl Acad Sci U S A. 2016 Oct 31. pii: 201522597.
    PubMed     Abstract available


  324. RAMEY AM, Spackman E, Kim-Torchetti M, DeLiberto TJ, et al
    Weak support for disappearance and restricted emergence/persistence of highly pathogenic influenza A in North American waterfowl.
    Proc Natl Acad Sci U S A. 2016;113:E6551-E6552.
    PubMed    


  325. LIANG R, Swanson JM, Madsen JJ, Hong M, et al
    Acid activation mechanism of the influenza A M2 proton channel.
    Proc Natl Acad Sci U S A. 2016 Oct 24. pii: 201615471.
    PubMed     Abstract available


  326. MOREIRA EA, Locher S, Kolesnikova L, Bolte H, et al
    Synthetically derived bat influenza A-like viruses reveal a cell type- but not species-specific tropism.
    Proc Natl Acad Sci U S A. 2016 Oct 24. pii: 201608821.
    PubMed     Abstract available


  327. HE W, Tan GS, Mullarkey CE, Lee AJ, et al
    Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
    Proc Natl Acad Sci U S A. 2016 Oct 3. pii: 201609316.
    PubMed     Abstract available


    September 2016
  328. LEON PE, He W, Mullarkey CE, Bailey MJ, et al
    Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.
    Proc Natl Acad Sci U S A. 2016 Sep 19. pii: 201613225.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: